These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21736067)

  • 21. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
    Likar R; Kayser H; Sittl R
    Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opiates for chronic nonmalignant pain?
    Grosshandler S; Stratas NE
    N C Med J; 1996; 57(5):288-90. PubMed ID: 8854692
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug treatment of tumor pain].
    Larsen B; Macher F
    Urologe A; 1994 Sep; 33(5):W457-73. PubMed ID: 7526520
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pain in tumor patients: assessment and pain drug therapy].
    Joss R; Bünter B; Schefer H
    Praxis (Bern 1994); 2004 Jan; 93(3):45-51. PubMed ID: 15032031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OROS® hydromorphone in chronic pain management: when drug delivery technology matches clinical needs.
    Coluzzi F; Mattia C
    Minerva Anestesiol; 2010 Dec; 76(12):1072-84. PubMed ID: 21102402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chronic pain therapy].
    Buettner UW
    Praxis (Bern 1994); 2009 Aug; 98(16):885-91. PubMed ID: 19672828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender and opioid analgesic response.
    Neafsey PJ; Keenan S
    Home Healthc Nurse; 2004 Dec; 22(12):812-3. PubMed ID: 15597000
    [No Abstract]   [Full Text] [Related]  

  • 30. Comment: therapy switching in patients receiving long-acting opioids.
    White R
    Ann Pharmacother; 2004 Oct; 38(10):1752-3; author reply 1753. PubMed ID: 15340135
    [No Abstract]   [Full Text] [Related]  

  • 31. 10-year follow-up of chronic non-malignant pain patients: opioid use, health related quality of life and health care utilization.
    Jensen MK; Thomsen AB; Højsted J
    Eur J Pain; 2006 Jul; 10(5):423-33. PubMed ID: 16054407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
    Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
    J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caring for adults with chronic cancer pain.
    Bral EE
    Am J Nurs; 1998 Apr; 98(4):26-32; quiz 33. PubMed ID: 9556680
    [No Abstract]   [Full Text] [Related]  

  • 35. Open-label study on the long-term efficacy, safety, and impact on quality of life of OROS hydromorphone ER in patients with chronic low back pain.
    Wallace M; Thipphawong J
    Pain Med; 2010 Oct; 11(10):1477-88. PubMed ID: 21199302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Opioids in rheumatology].
    Babić-Naglić D
    Reumatizam; 2002; 49(2):29-32. PubMed ID: 12476758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study.
    Ridgway D; Sopata M; Burneckis A; Jespersen L; Andersen C
    J Pain Symptom Manage; 2010 Apr; 39(4):712-20. PubMed ID: 20413058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Opioids in the treatment of pain--efficient weapon in the expert's hand].
    Kalso E
    Duodecim; 2004; 120(2):195-6. PubMed ID: 15065513
    [No Abstract]   [Full Text] [Related]  

  • 39. Do patients prefer transdermal fentanyl or sustained-release oral morphine for treatment of chronic non-cancer pain?
    Heidemann AJ; Seaton TL
    J Fam Pract; 2001 Oct; 50(10):897. PubMed ID: 11674896
    [No Abstract]   [Full Text] [Related]  

  • 40. [Opioids: wide range of indications, good tolerance].
    Uberall MA
    Krankenpfl J; 2005; 43(7-10):202. PubMed ID: 16515273
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.